ÍøºìºÚÁÏ

Skip to main content

Michael S Okun, MD : Research

Neurologist

Photo of Michael S Okun

Research at a glance

Top areas of exploration

  • Parkinson Disease , 350 publications
  • Deep Brain Stimulation , 263 publications
  • Globus Pallidus , 60 publications
  • Subthalamic Nucleus , 58 publications

Research activity

794 publications

33,008 citations

Why is this important?

Active clinical trials

TS MOD CM GPI

The investigators will implant and monitor 8 research subjects with a subcortical closed-loop system for detection and suppression of tics in subjects with medically refractory debilitating Tourette Syndrome. The project will use the FDA-approved…

Investigator
Michael S Okun
Status
Accepting Candidates
Ages
18 Years - 85 Years
Sexes
All
Vercise DBS Registry

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming…

Investigator
Michael S Okun
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
TAA Database
Investigator
Michael S Okun
Status
Accepting Candidates

My publications

794 publications

2024

U.S. Tax Credits to Promote Practical Proactive Preventative Care for Parkinson's Disease.

Journal of Parkinson's disease

•

2024

A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society

•

2024

Management of essential tremor deep brain stimulation-induced side effects.

Frontiers in human neuroscience

•

2024

Proceedings of the 11th Annual Deep Brain Stimulation Think Tank: pushing the forefront of neuromodulation with functional network mapping, biomarkers for adaptive DBS, bioethical dilemmas, AI-guided neuromodulation, and translational advancements.

Frontiers in human neuroscience

•

2024

Current perspectives on tractography-guided deep brain stimulation for the treatment of mood disorders.

Expert review of neurotherapeutics

•